Temperature Management in Neurological and Neurosurgical Intensive Care Unit

Lyden, Patrick D.; Kapinos, Gregory; Sekhon, Mypinder S.; Levi, Allan D.

doi:10.1089/ther.2020.29072.pjl

Cited by 1 publication

(1 citation statement)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A better approach would be to target more global secondary cell death mechanism(s) that occur in multiple neural cell types. In the past, hypothermia has been used in a similar therapeutic strategy [ 14 , 15 , 16 ] and currently, multiple prospective multi-center clinical trials in SCI are ongoing ( as accessed on 20 October 2022) (see [ 17 ], for a recent discussion). Moreover, as cell death is a response to damage, interventions that promote the repair of such damage and restore cellular homeostasis may be needed for long-term tissue integrity and restoration of function.…”

Section: Introductionmentioning

confidence: 99%

The Proteostasis Network: A Global Therapeutic Target for Neuroprotection after Spinal Cord Injury

Whittemore

Ohri

Forston

et al. 2022

Cells

View full text Add to dashboard Cite

Proteostasis (protein homeostasis) is critical for cellular as well as organismal survival. It is strictly regulated by multiple conserved pathways including the ubiquitin-proteasome system, autophagy, the heat shock response, the integrated stress response, and the unfolded protein response. These overlapping proteostasis maintenance modules respond to various forms of cellular stress as well as organismal injury. While proteostasis restoration and ultimately organism survival is the main evolutionary driver of such a regulation, unresolved disruption of proteostasis may engage pro-apoptotic mediators of those pathways to eliminate defective cells. In this review, we discuss proteostasis contributions to the pathogenesis of traumatic spinal cord injury (SCI). Most published reports focused on the role of proteostasis networks in acute/sub-acute tissue damage post-SCI. Those reports reveal a complex picture with cell type- and/or proteostasis mediator-specific effects on loss of neurons and/or glia that often translate into the corresponding modulation of functional recovery. Effects of proteostasis networks on such phenomena as neuro-repair, post-injury plasticity, as well as systemic manifestations of SCI including dysregulation of the immune system, metabolism or cardiovascular function are currently understudied. However, as potential interventions that target the proteostasis networks are expected to impact many cell types across multiple organ systems that are compromised after SCI, such therapies could produce beneficial effects across the wide spectrum of highly variable human SCI.

show abstract